BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,004,000 | +3.5% | 943,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $970,000 | -95.1% | 943,000 | -94.8% | 0.01% | -94.0% |
| Q4 2017 | $19,631,000 | -24.1% | 18,165,000 | -21.6% | 0.10% | -50.0% |
| Q3 2017 | $25,861,000 | -0.3% | 23,155,000 | -0.7% | 0.20% | +4.2% |
| Q2 2017 | $25,941,000 | -41.0% | 23,321,000 | -39.8% | 0.19% | -44.5% |
| Q1 2017 | $43,974,000 | +0.0% | 38,745,000 | -0.9% | 0.35% | -0.9% |
| Q4 2016 | $43,956,000 | +61.3% | 39,088,000 | +71.9% | 0.35% | +79.0% |
| Q3 2016 | $27,258,000 | +7.7% | 22,734,000 | -0.4% | 0.20% | +9.6% |
| Q2 2016 | $25,317,000 | -6.1% | 22,817,000 | -2.0% | 0.18% | -0.6% |
| Q1 2016 | $26,954,000 | -10.6% | 23,288,000 | -0.4% | 0.18% | -6.8% |
| Q4 2015 | $30,163,000 | +177.3% | 23,381,000 | +181.4% | 0.19% | +156.0% |
| Q3 2015 | $10,876,000 | -16.7% | 8,308,000 | -1.1% | 0.08% | -7.4% |
| Q2 2015 | $13,056,000 | +4.0% | 8,398,000 | -1.2% | 0.08% | +2.5% |
| Q1 2015 | $12,552,000 | +260.2% | 8,502,000 | +188.0% | 0.08% | +243.5% |
| Q4 2014 | $3,485,000 | -27.5% | 2,952,000 | -34.9% | 0.02% | -28.1% |
| Q3 2014 | $4,807,000 | -72.7% | 4,535,000 | -73.3% | 0.03% | -71.4% |
| Q2 2014 | $17,609,000 | -60.0% | 16,998,000 | -58.0% | 0.11% | -60.3% |
| Q1 2014 | $44,067,000 | +3.3% | 40,441,000 | +1.3% | 0.28% | +4.1% |
| Q4 2013 | $42,647,000 | – | 39,932,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|